Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Financial toxicity may be common in gynecologic cancer patients

Publish date:: March 17, 2019

Key clinical point: Financial toxicity may be common in gynecologic cancer patients starting a new line of therapy.

Major finding: Financial toxicity was reported by 54% of 121 gynecologic cancer patients surveyed.

Study details: Online and in-person surveys of 121 patients

Disclosures: The speaker reported no disclosures.

Citation:

Liang M et al. SGO 2019. Abstract 8.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Gynecologic Cancer

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

Is diagnostic hysteroscopy safe in patients with type 2 endometrial cancer?,

Cervical cancer recurrence patterns differ after laparoscopic and open hysterectomy,

Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest,

Half of women treated for gynecologic cancers miss or skip doses of oral drugs,